help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiu, J.
Right arrow Articles by Chen, Y.-z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiu, J.
Right arrow Articles by Chen, Y.-z.
Endocrinology Vol. 139, No. 12 5103-5108
Copyright © 1998 by The Endocrine Society

ARTICLES

Nongenomic Mechanisms of Glucocorticoid Inhibition of Nicotine-Induced Calcium Influx in PC12 Cells: Involvement of Protein Kinase C1

Jian Qiu, Li-guang Lou, Xiu-ying Huang, Shu-jie Lou, Gang Pei and Yi-zhang Chen

Neuroscience Research Institute, Second Military Medical University (J.Q., S.-J.L., Y.-z.C.); and the Key Laboratory of Neurobiology, Shanghai Institute of Physiology (J.Q.), the Shanghai Institute of Cell Biology (L.-g.L., G.P.), and the Beijing Institute of Developmental Biology (X.-y.H.), Chinese Academy of Sciences, Shanghai 200433, China

Address all correspondence and requests for reprints to: Dr. Y. Z. Chen, Neuroscience Research Institute, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, China.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Nongenomic mechanisms of corticosterone (B) inhibition of nicotine (Nic)-induced calcium influx were investigated in PC12 cells. Corticosterone could rapidly inhibit the Ca2+ influx induced by Nic, and BSA-conjugated B had a similar inhibitory effect. The inhibition of Nic-induced Ca2+ influx by B could be mimicked by protein kinase C (PKC) activator (phorbol 12-myristate 13-acetate) and reversed by PKC inhibitors, chelerythrine chloride and Gö6976. When PC12 cells were pretreated with pertussis toxin, the inhibitory effect of B on Nic-induced Ca2+ influx was blocked. Both B and BSA-conjugated B could activate PKC activity, with the maximal responses at 10-9 and 10-7 M at 37 C, respectively. The dose-response curve was bell shaped. At 25 C, however, the dose-response curve considerably shifted to the right, and B was most potent at 10-5 M. The time course showed that PKC activity was highest at 5 min of B’s action. The results suggest that B might act via putative membrane receptors and inhibit the Ca2+ influx induced by Nic through the pertussis toxin-sensitive G protein-PKC pathway and that PKC plays an important role in the mechanisms of glucocorticoid nongenomic action.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
IN RECENT years, the intracellular mechanism of glucocorticoid’s rapid nongenomic action has attracted more and more attention (1, 2, 3, 4). It has been observed in our laboratory that glucocorticoid affects the membrane potential of excitable cells such as neurons within minutes or seconds (1). Corticosterone (B) inhibits the release of arginine vasopressin from rat hypothalamic slices and the secretion of catecholamine in rat adrenal medullary chromaffin cells (5, 6).

In all types of cells, intracellular calcium, as a second messenger, plays an important role in many physiological activities including contraction, neurite outgrowth, and neurotransmitter and hormone secretion. There is an increasing body of data concerning the rapid effects of glucocorticoid on the intracellular calcium concentration ([Ca2+]i). B inhibits calcium inflow in rat pancreatic islets (7). Cortisol rapidly reduces 45Ca2+ accumulation in the cichlid fish pituitary in vitro (8) and inhibits calcium currents in guinea pig hippocampal CA1 neurons via G protein-coupled activation of protein kinase C (9). Glucocorticoid suppressed intracellular calcium release in adenohypophyseal cells (10) and enhanced 45Ca2+ uptake induced by 70 mM K+ in prepared brain synaptosomes (11). Recently in our laboratory, it has been demonstrated that corticosterone inhibits the increase in [Ca2+]i induced by acetylcholine (ACh) and high potassium in rat adrenal medullary chromaffin cells (6) and inhibits the Ca2+ influx induced by bradykinin while not affecting intracellular Ca2+ release in PC12 cells (12).

The mechanism of the rapid effects of glucocorticoid on intracellular calcium is not clear. In the present study, we analyzed how glucocorticoid affects nicotine (Nic)-induced Ca2+ influx and further investigated the signal transduction pathway of glucocorticoid’s rapid nongenomic action, especially G protein and protein kinase C (PKC) that may be involved. Our results have shown that glucocorticoid inhibits the Ca2+ influx induced by Nic through a putative membrane receptor-mediated, pertussis toxin (PTX)-sensitive G protein-PKC pathway and for the first time directly demonstrated that PKC plays an important role in the nongenomic action by PKC activity assay.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Materials
Pluronic F-127, fura-2/AM, EGTA, pertussis toxin (PTX), Gö6976, chelerythrine chloride (chelery), phorbol 12-myristate 13-acetate (PMA), ionomycin calcium salt, and phenylmethylsulfonylfluoride were obtained from Calbiochem (La Jolla, CA). B 21-sulfate, (±)nicotine, BSA (fatty acid free), B 21-hemisuccinate:BSA, verapamil hydrochloride (Vp), {omega}-conotoxin GVIA ({omega}-CTX), and ß-mercaptoethanol were purchased from Sigma Chemical Co. (St. Louis, MO). All other chemicals used were of analytical grade.

Cell culture
PC12 cells were the generous gift of Dr. K. Kuba (Department of Physiology, Saga Medical School, Saga, Japan). PC12 cells were grown in DMEM with high glucose (Life Technologies, Grand Island, NY) supplemented with 5% heat-inactivated FBS and 10% heat-inactivated horse serum and incubated in a humidified atmosphere containing 5% CO2 in air at 37 C. Flasks used to culture PC12 cells had been coated with mouse tail collagen to facilitate cell adherence to the surface of the substrate.

[Ca2+]i measurements
PC12 cells grown on a 30-mm diameter dish with 70–80% confluence were washed three times with physiological saline solution (PSS; containing 125 mmol/liter NaCl, 5.6 mmol/liter KCl, 2 mmol/liter CaCl2, 1.2 mmol/liter MgSO4·7H2O, 1.2 mmol/liter NaH2PO4·2H2O, 10 mmol/liter HEPES, and 10 mmol/liter glucose, pH 7.4). Cells were harvested by gently streaming PSS on the surface of the monolayers and then dissociated to yield single cell by passing cells through a pipette. They were suspended in 2 ml PSS containing 0.004% (wt/vol) pluronic, then loaded with 5 µmol/liter fura-2/AM for 40 min at 37 C. At the end of the loading period they were rinsed with PSS and resuspended in 2 ml PSS. Cells were kept at 25 C in the dark and were used within 2 h.

At the beginning of [Ca2+]i determination, 60 µl loaded cell suspension were added to glass coverslips coated with collagen and incubated in an incubator for 15 min at 37 C, then the coverslip was placed in a thermostatically ring chamber holding 300 µl incubation fluid. All drugs were added in volumes of less than 3 µl. All experiments were performed at room temperature (25 C) to minimize dye leakage.

The system used in our laboratory for calcium imaging and [Ca2+]i measurement was the MiraCal Imaging System supplied by Life Science Resources Ltd. (Cambridge, UK). It consisted of a Nikon Diaphot 200 inverted fluorescence microscope coupled to a MiraCal 1000TE low light level CCD camera and a computer station. Images were captured and quantitatively analyzed by the MiraCal version 2.3 software program (Life Sciences Resources). The peak excitation wavelength of the fura-2 shift from 380 to 340 nm upon Ca2+ binding and the ratio of emission intensities in each wavelength provide a measure of free [Ca2+]i. Changes in [Ca2+]i in the PC12 cells were imaged through a Nikon CF-fluor 10x or 20x objective (Melville, NY) and the CCD camera by calculating the ratio of fura-2 fluorescence at 510 nm, excited by UV light alternately at 340 and 380 nm. The light source was a 75-watt xenon and dual monochromater system. The intensity of the UV light was reduced by neutral density filters. Pairs of 340- and 380-nm images were obtained at 3.0-sec intervals and were corrected for background. Ratio images were calculated by computer, and the free [Ca2+]i was calculated using the well known ratio equation (13).

PKC activity assay
PC12 cells were resuspended in serum-free DMEM. After drug treatment, cells were washed twice with PBS and homogenized on ice in lysis buffer (25 mM Tris, 0.5 mM EGTA, 0.5 mM EDTA, 10 mM ß-mercaptoethanol, 1 µg/ml leupeptin, 1 µg/ml aprotinin, and 1 mM phenylmethylsulfonylfluoride). Homogenates were centrifuged at 86,000 x g for 30 min at 4 C. The pellet was resuspended in lysis buffer containing 0.5% Triton X-100 and homogenized again. The supernatant containing the solubilized membranes was used as the membrane fraction (14). PKC activity in the membrane fractions was measured using the SignaTECT PKC assay system from Promega Corp. (Madison, WI) according to the manufacturer’s instructions. Protein concentrations were determined using the Bio-Rad protein assay kit with BSA as the reference standard (15).

Statistical analysis
The statistical significance of differences between the groups was assessed by Student’s t test. Differences were considered significant at P < 0.05.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Effect of B on Nic-induced increase in [Ca2+]i
As shown in Fig. 1Go, B could rapidly inhibit the Ca2+ influx induced by Nic. As the concentration of B increased, the inhibition of B on the increase in [Ca2+]i caused by Nic was also gradually enhanced. The IC50 was 0.61 ± 0.19 µM.



View larger version (23K):
[in this window]
[in a new window]
  		Figure 1. Effect of B on Nic-induced increase in [Ca2+]i. A, Cells were preincubated with B at the various concentrations indicated at 25 C for 5 min and then were stimulated with Nic (100 µM). [Ca2+]i was determined as described in the text. Data are presented as the mean ± SE (n = 20 cells/data point); they represent the maximal calcium concentration over basal or resting values. The IC50 value for B to block the Nic-induced increase in [Ca2+]i was 0.61 ± 0.19 µM. B and C, Two representative real traces in A for 10-10 and 10-6 M B, respectively.

 
Effects of B, B-conjugated BSA (B-BSA), PKC inhibitors, activator, and blockers of voltage-gated Ca2+ channels on Nic-induced increase in [Ca2+]i
As shown in Fig. 2Go, after incubation with Ca2+ channel blockers (Vp and co-CTX), the increase in [Ca2+]i induced by Nic was significantly blocked, suggesting that the Nic-induced increase in [Ca2+]i is primarily through Ca2+ influx. The inhibitory effect of B-BSA on Ca2+ influx induced by Nic was the same as the effect of free B. This suggested that B might act via putative membrane receptors. Furthermore, PKC activator (PMA) could mimic whereas PKC inhibitors, chelery and Gö6976, could reverse the inhibitory effect of B. These indicated that Ca2+-dependent PKCs are probably involved in the suppressive effect of B on calcium influx induced by Nic.



View larger version (43K):
[in this window]
[in a new window]
  		Figure 2. Effects of B, B-BSA, PKC inhibitors, activator, and blockers of voltage-gated Ca2+ channels on the Nic-induced increase in [Ca2+]i. PC12 cells were treated with drugs, then [Ca2+]i was determined as described in the text. PKC inhibitors (chelery, 10 µM; Gö6976, 0.1 µM), activator (PMA, 100 nM), and blockers of voltage-gated Ca2+ channels (Vp, 20 µM; {omega}-CTX, 500 nM) were given 10 min before Nic, B (1 µM and B-BSA (1 µM) were given 5 min before Nic (100 µM). Data are presented as the mean ± SE (n = 20 cells/data point); they represent the maximal calcium concentration over basal or resting values. **, P < 0.01 vs. the Nic group, respectively.

 
Effect of B on Nic-induced increase in [Ca2+]i when pretreated with PTX
To clarify the molecular mechanism of the nongenomic effect of glucocorticoid suppression on Ca2+ influx induced by Nic, we studied the involvement of G protein, which is known to modulate many functions of receptor-mediated cellular events, including activation of PKC activity and/or gating of ion channels. As shown in Fig. 3Go, after pretreating PC12 cells with PTX (100 ng/ml) for 24 h, no noticeable inhibitory effect of B on Ca2+ influx induced by Nic could be observed. This indicated that the action of B may be through PTX-sensitive G protein.



View larger version (38K):
[in this window]
[in a new window]
  		Figure 3. Effect of B on the Nic-induced increase in [Ca2+]i in PTX-pretreated PC12 cells. Cells were pretreated with or without PTX (100 ng/ml) for 24 h, then preincubated with or without B (1 µM) at 25 C for 5 min, and Nic was added (100 µM). [Ca2+]i was determined as described in the text. Data represent the mean ± SE (n = 20 cells/data point); they represent the maximal calcium concentration over basal or resting values. P > 0.05 vs. the control group.

 
Effects of B and B-BSA on PKC activity in PC12 cells
It is now generally accepted that activation of PKC is associated with translocation of the enzyme (16). To determine whether B could activate PKC in resting PC12 cells, we measured PKC activity in the membrane fractions. As shown in Fig. 4Go, B could activate PKC activity, and the PKC inhibitor chelery could completely block the activation by B.



View larger version (27K):
[in this window]
[in a new window]
  		Figure 4. Effect of PKC inhibitor (chelery) on PKC activity stimulated by B in PC12 cells. Cells were exposed to different drugs (B, 1 nM; PMA, 100 nM) at 37 C for 5 min after preincubation with or without chelery (10 µM) for 15 min, then PKC activity in the membrane fractions was assayed as described in the text. Data represent the mean ± SE of three to five experiments. **, P < 0.01 vs. the B group.

 
The time course showed that the PKC activity was kept at a higher level from 5–15 min of B’s action and was highest at 5 min (Fig. 5Go). This finding explained why the inhibitory effect was most efficient after 5-min preincubation with B min before the addition of Nic.



View larger version (16K):
[in this window]
[in a new window]
  		Figure 5. Time course of activation of PKC by B in PC12 cells. Cells were exposed to B (1 nM) at 37 C for the time intervals indicated, then PKC activity in the membrane fractions was determined as described in the text. Data represent the mean ± SE of three to five experiments.

 
As shown in Fig. 6Go, B and B-BSA activated PKC activity. The dose-response curve was bell shaped. B was most potent at 10-9 M, but B-BSA was most potent at 10-7 M at 37 C. At 25 C, however, the dose-response curve considerably shift to the right, and B was most potent at 10-5 M (Fig. 7Go).



View larger version (24K):
[in this window]
[in a new window]
  		Figure 6. Dose-dependent activation of PKC by B and B-BSA in PC12 cells. Cells were exposed to B or B-BSA at various concentrations at 37 C for 5 min, then PKC activity in the membrane fractions was assayed as described in the text. Data represent the mean ± SE of three to five experiments. ** and ##, P < 0.01 vs. basal.

 


View larger version (24K):
[in this window]
[in a new window]
  		Figure 7. Dose-dependent activation of PKC by B in PC12 cells at 25 and 37 C. Cells were exposed to B at various concentrations for 5 min, then PKC activity in the membrane fractions was assayed as described in the text. Data represent the mean ± SE of three to five experiments. ** and ##, P < 0.01 vs. basal.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Nicotinic ACh receptors are expressed in PC12 cells (17). Nic would be expected to raise [Ca2+]i due to Ca2+ entry predominantly through voltage-dependent channels and additionally through nicotinic receptor-associated channels. After incubation with Vp and co-CTX, the increase in [Ca2+]i induced by Nic was significantly blocked, suggesting that the Nic-induced increase in [Ca2+]i is mainly through its influx. Our results are in accordance with the reports that there are predominantly L-type Ca2+ channels, with N-type Ca2+ channels in the minority, in undifferentiated PC12 cells (18).

The peak free B concentration in rat serum reached 7.5 x 10-7 M during stress (19). The adrenal medulla in mammals is encapsulated by the adrenal cortex, and venous blood from the latter drains through the former in the intraadrenal portal vascular system before entering the general circulation. This vascular system subjects the chromaffin cells of the medulla to extremely high concentrations of adrenal cortical hormones, 2 orders of magnitude higher than those in the peripheral circulation (20). Thus, it is very likely that the glucocorticoid inhibits Nic-induced calcium influx in concentrations within the physiological range.

In a previous study, we have shown the time course of the inhibitory effect of B on the increase in [Ca2+]i induced by high K+ in PC12 cells, with the maximal effect at 5 min (21). In the present experiment, B could rapidly inhibit the Ca2+ influx induced by Nic after preincubation with B for 5 min. In good agreement with the above-mentioned results is the finding that B activated the PKC activity, with the maximal effect also at 5 min. As for B-activated PKC activity, the maximal response was 10-9 M at 37 C, which is 4 orders of magnitude lower than that at 25 C (10-5 M). The mechanism for the rightward shift in dose response at 25 C after B treatment is not yet clear. It is probably due to the influence of temperature itself, as temperature usually greatly alters the activity of enzymes.

In addition to the intracellular glucocorticoid receptor, plasma membranes in several types of cells have binding sites for glucocorticoids (22, 23, 24, 25). In our study, B-BSA could also activate PKC activity. As B-BSA is practically membrane impermeable, our results here provide support for the idea that B might act via putative glucocorticoid membrane receptors. The data in Fig. 6Go show that the maximal effect on PKC activity was at 10-7 M for B-BSA, 2 orders higher than that of free B. This rightward shift is probably caused by the hindrance effect, because BSA is a very big molecule that may hinder, and therefore attenuate, the action of B in B-BSA.

It is known that undifferentiated PC12 cells contain PKC{alpha}, -{delta}, -{epsilon}, and -{zeta} (26, 27). Our finding that Gö6976, which is a compound that inhibits PKC{alpha} and -ß specifically, could block the effect of B indicated that PKC{alpha} is probably involved in the suppressive effect of B on calcium influx induced by Nic.

Glucocorticoids have been reported to inhibit the ACh-induced current in chromaffin cells and were reported to bind to the specific site on the outer cell membrane, probably on the ACh receptor-coupled channel (28). In our results, the mechanism of the inhibitory action of glucocorticoid may not be channel blocking, because PKC activator (PMA) could mimic the inhibitory effect of the B and PKC inhibitors, chelery and Gö6976, could reverse the inhibitory effect of B. Phosphorylation of AChR has been implicated in regulation of the ligand-gated ion channel. PKC has been shown to enhance receptor desensitization (29, 30). On the other hand, PKC can inhibit two types of calcium currents in GH3 cells (31), and the activity of N-type channels was regulated through phosphorylation by PKC (32). Furthermore, activation of PKC could reduce L-type calcium channel activity in PC12 cells (33, 34, 35) as well as GH3 pituitary cells (36), pituitary AtT-20 cells (37), and cultured embryonic chick dorsal root ganglion neurons (38). Our data suggest at least two possible sites of action for the nongenomic effect of glucocorticoid through phosphorylation by PKC. One is at AChR, and another is at calcium channels.

In Taricha, results from radioligand binding assays demonstrated that [3H]B binding in neuronal membranes is negatively modulated by nonhydrolyzable guanine nucleotide analogs, especially GTP-{gamma}-S (39). Other studies revealed that [3H]B-specific binding was enhanced in a concentration-dependent manner by adding Mg2+ to the assay buffer. These results are consistent with comparable studies for known G protein-coupled receptors and provide evidence that the putative membrane receptor of B is coupled to G protein (40). Furthermore, it has been reported that cortisol inhibits the calcium currents in guinea pig hippocampal CA1 neurons via G protein-coupled activation of PKC (9). Clearly, our data also indicated that the nongenomic action of B may be through a PTX-sensitive G protein-PKC pathway. More importantly our study demonstrates for the first time rapid stimulation of PKC activity by glucocorticoid in PC12 cells.

Previous studies have shown that glucocorticoids could rapidly inhibit the cAMP production and PRL release induced by vasoactive intestinal peptide by acting through specific glucocorticoid receptors in normal rat pituitary cells in culture (41), and cortisol also rapidly reduces PRL release and cAMP in the cichlid fish pituitary in vitro (8). In glucocorticoid inhibition of ACTH secretion and cAMP, the possible involvement of a PTX-sensitive G protein has been indicated in the mouse corticotroph tumor cell line AtT20 (42), but our data suggested that there were no effects of B on resting, forskolin-induced changes in cAMP accumulation and protein kinase A activity (not shown) in PC12 cells. These data indicated that the nongenomic signal transduction mechanisms of glucocorticoid’s rapid action varied in different tissues or cells.

Based on our data, a new model of the rapid nongenomic action of B in PC12 cells is proposed (as summarized in Fig. 8Go). In summary, glucocorticoid might act via putative membrane receptors and inhibit the Ca2+ influx induced by Nic through the PTX-sensitive G protein-PKC pathway in PC12 cells. PKC plays an important role in the mechanism of the nongenomic action of glucocorticoid.



View larger version (24K):
[in this window]
[in a new window]
  		Figure 8. A model of the rapid nongenomic action of B in PC12 cells. The steps that are not well defined are indicated by arrows with dashed lines. R, G protein-coupled B receptor; G, G protein; VOCs, voltage-operated channels; N-AChR, nicotinic ACh receptor; BK, bradykinin; PC12 cells, pheochromocytoma cells.

 


   Acknowledgments
 
We thank Drs. Guo-huang Fan and Zhi-jie Chen (Shanghai Institute of Cell Biology, Shanghai, China) and Chen-guang Wang (Beijing Institute of Developmental Biology, Beijing, China) for their helpful discussions.


   Footnotes
 
1 This work was supported by a research grant from the Natural Science Foundation of China. Back

Received June 15, 1998.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hua SY, Chen YZ 1989 Membrane-receptor mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology 124:687–691[Abstract]
  2. McEwen BS 1991 Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12:141–147[CrossRef][Medline]
  3. Schumacher M 1990 Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci 13:359–362[CrossRef][Medline]
  4. Grazzini E, Guillon G, Mouillac B, Zingg HH 1998 Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392:509–512[CrossRef][Medline]
  5. Liu X, Chen YZ 1995 Membrane-mediated inhibition of corticosterone on the release of arginine vasopressin from rat hypothalamic slices. Brain Res 704:19–22[CrossRef][Medline]
  6. Song L, Chen YZ 1997 The rapid inhibitory effects of glucocorticoids on the secretion of catecholamine in rat adrenal medullary chromaffin cells. Chin J Neurosci 4:16–21
  7. Billaudel B, Mathias PCF, Sutter BCJ, Malaisses WJ 1984 Inhibition by corticosterone of calcium inflow and insulin release in rat pancreatic islets. J Endocrinol 100:227–233[Abstract/Free Full Text]
  8. Borski RJ, Helms LIH, Richaman HR, Grau EE 1991 Cortisol rapidly reduces prolactin release and cAMP and 45Ca2+ accumulation in cichlid fish pituitary in vitro. Proc Natl Acad Sci USA 88:2758–2762[Abstract/Free Full Text]
  9. Ffrench-Mullen JMH 1995 Cortisol inhibition of calcium currents in guinea pig hippocampal CA1 neurons via G-protein coupled activation of protein kinase C. J Neurosci 15:903–911[Abstract]
  10. Antoni FA, Hoyland J, Woods MD, Mason WT 1992 Glucocorticoid inhibition of stimulus-evoked adrenocorticotropin release caused by suppression of intracellular calcium signals. J Endocrinol 133:R13–R16
  11. Sze PY, Igball Z 1994 Glucocorticoid action on depolarization dependent calcium influx in brain synaptosomes. Neuroendcrinology 59:457–465[Medline]
  12. Chen YZ, Lou SJ, Qiu J Mechanism of rapid inhibition of catecholamine secretion from, and of intracellular calcium increment by glucocorticoid in PC12 cells XXXIII. International Congress of Physiological Sciences, St. Petersburg, FL, 1997, L007.04 (Abstract)
  13. Grynikewicz G, Poenie M, Tsien RY 1985 A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450[Abstract/Free Full Text]
  14. Lou LG, Pei G 1997 Modulation of protein kinase C and cAMP-dependent protein kinase by {delta}-opioid. Biochem Biophys Res Commun 236:626–629[CrossRef][Medline]
  15. Bradford MM 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  16. Liu JP 1996 Protein kinase C and its substrates. Mol Cell Endocrinol 116:1–29[CrossRef][Medline]
  17. Greene LA, Rein G 1977 Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res 129:247–263[CrossRef][Medline]
  18. Shafer TJ, Atchison WD 1991 Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12:473–492[Medline]
  19. Yeh KY 1984 Corticosterone concentrations in the serum and milk of lactating rats parallel changes after induced stress. Endocrinology 15:1364–1370
  20. Jones MT, Hillhouse EW, Burden JL 1977 J. Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland. Endocrinology 73:405–417
  21. Lou SJ, Chen YZ 1998 The rapid inhibitory effect of glucocorticoid on cytosolic free Ca2+ increment induced by high extracellular K+ and its underlying mechanism in PC12 cells. Biochem Biophys Res Commun 244:403–407[CrossRef][Medline]
  22. Harrison RW, Fairfield S, Orth DN 1976 Multiple glucocorticoid binding components of intact AtT-20/D-1 mouse pituitary tumor cells. Biochim Biophys Acta 444:487–496[Medline]
  23. Koch B, Lutz-Bucher B, Briand B, Mialhe C 1978 Specific interaction of corticosteroids with binding sites in the plasma membranes of the rat anterior pituitary gland. J Endocrinol 79:215–222[Abstract/Free Full Text]
  24. Towle AC, Sze PY 1983 Steroid binding to synaptic plasma membrane: differential binding of glucocorticoids and steroids. J Steroid Biochem 18:135–143[CrossRef][Medline]
  25. Guo Z, Chen YZ, Xu LB, Fu H 1995 Binding characteristics of glucocorticoid receptors in synaptic plasma membrane from rat brains. Funct Neurol 10:175–194[Medline]
  26. Ohmichi M, Zhu G, Saltiel A R 1993 Nerve growth factor activates calcium-insensitive protein kinase C-epsilon in PC12 rat pheochromocytoma cells. Boichem J 295:767–772
  27. Zheng WH, Fink DW Jr, Guroff G 1996 Role of protein kinase C {alpha} in nerve growth factor-induced arachidonic acid release from PC12 cells. J Neurochem 66:1868–1875[Medline]
  28. Inoue M, Kuriyama H 1989 Glucocorticoids inhibit acetylcholine-induced current in chromaffin cells. Am J Physiol 257:C906–C912
  29. Eusebi F, Molinaro M, Zani BM 1985 Agents that activate protein kinase C reduce acetylcholine sensitivity in cultured myotubes. J Cell Biol 100:1339–1342[Abstract/Free Full Text]
  30. Safran A, Provenzano C, Sagi-Eisenberg R, Fuchs S 1990 Phosphorylation of membrane-bound acetylcholine receptor by protein kinase C: characterization and subunit specificity. Biochemistry 29:6730–6734[CrossRef][Medline]
  31. Marchetti C, Brown AM 1988 Protein kinase activator 1-oleoyl-2-acetyl- sn-glycerol inhibits two types of calcium currents in GH3 cells. Am J Physiol 254:C206–C210
  32. Hell JW, Appleyard SM, Yokoyama CT, Warner C, Catterall WA 1994 Differential phosphorylation of two size forms of the N-type calcium channel 1 subunit which have different COOH termini. J Biol Chem 269:7390–7396[Abstract/Free Full Text]
  33. Harris KM, Knogsamut S, Miller RJ 1986 Protein kinase C mediated regulation of calcium channels in PC12 pheochromocytoma cells. Biochem Biophys Res Commun 134:1298–1305[CrossRef][Medline]
  34. Di Virgilio F, Pozzan T, Wollheim CB, Vicentini LM, Meldolesi J 1986 Tumor promoter phorbol myristate acetate inhibits Ca2+ influx through voltage-gated Ca2+ channels in two secretary cell line, PC12 and RINm5F. J Biol Chem 261:32–35[Abstract/Free Full Text]
  35. Bouron A, Reber BFX 1994 Differential modulation of pharmacologically distinct components of Ca2+ currents by protein kinase C activators and phosphatase inhibitors in nerve growth factor differentiated rat pheochromocytoma (PC12) cells. Pflugers Arch 427:510–516[CrossRef][Medline]
  36. Haymes A, Kwan YW, Arena JP, Kass RS, Hinle PM 1992 Activation of protein kinase C reduces L-type calcium channel activity of GH3 pituitary cells. Am J Physiol 262:C1211–C1219
  37. Lewis DI, Weight FF 1988 The protein kinase C activator 1-oleoyl-2-acetylglycerol inhibits voltage-dependent Ca2+ current in the pituitary cell line AtT-20. Neuroendocrinology 47:169–170[Medline]
  38. Rane SG, Dunlap K 1986 Kinase C activator 1,2-oleoylacetylglyceral attenuates voltage-dependent calcium current in sensory neurons. Proc Natl Acad Sci USA 83:184–188[Abstract/Free Full Text]
  39. Orchinik M, Murray TF, Franlelin PH, Moore FL 1992 Guanylnucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci USA 89:3830–3834[Abstract/Free Full Text]
  40. Moore FL, Orchinik M, Lonry C 1995 Functional studies of corticosterone receptors in neuronal membranes. Receptor 5:21–28[Medline]
  41. Rotsztejn W, Dussaillant M, Nobou F, Rosselin G 1981 Rapid glucocorticoid inhibition of vasoactive intestinal peptide induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc Natl Acad Sci USA 78:7584–7588[Abstract/Free Full Text]
  42. Iwasaki Y, Aoki Y, Katahira M, Oiso Y, Saito H 1997 Non-genomic mechanisms of glucocorticoid inhibition of adrenocorticotropin secretion: possible involvement of GTP-binding protein. Biochem Biophys Res Commun 235:295–299[CrossRef][Medline]



This article has been cited by other articles:


Home page
 EndocrinologyHome page
Y.-S. Park, Y. Ha Choi, C.-H. Park, and K.-T. Kim
Nongenomic Glucocorticoid Effects on Activity-Dependent Potentiation of Catecholamine Release in Chromaffin Cells
Endocrinology, October 1, 2008; 149(10): 4921 - 4927.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Furst, S. Zahler, and A. M. Vollmar
Dexamethasone-Induced Expression of Endothelial Mitogen-Activated Protein Kinase Phosphatase-1 Involves Activation of the Transcription Factors Activator Protein-1 and 3',5'-Cyclic Adenosine 5'-Monophosphate Response Element-Binding Protein and the Generation of Reactive Oxygen Species
Endocrinology, July 1, 2008; 149(7): 3635 - 3642.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Liu, M. Iruthayanathan, L. L. Homan, Y. Wang, L. Yang, Y. Wang, and J. S. Dillon
Dehydroepiandrosterone Stimulates Endothelial Proliferation and Angiogenesis through Extracellular Signal-Regulated Kinase 1/2-Mediated Mechanisms
Endocrinology, March 1, 2008; 149(3): 889 - 898.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Liu, H. Si, K. A. Reynolds, W. Zhen, Z. Jia, and J. S. Dillon
Dehydroepiandrosterone Protects Vascular Endothelial Cells against Apoptosis through a G{alpha}i Protein-Dependent Activation of Phosphatidylinositol 3-Kinase/Akt and Regulation of Antiapoptotic Bcl-2 Expression
Endocrinology, July 1, 2007; 148(7): 3068 - 3076.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
L. Wang, Y.-D. Wang, W.-J. Wang, Y. Zhu, and D.-J. Li
Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor
J. Mol. Endocrinol., April 1, 2007; 38(4): 467 - 479.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. G. Tasker, S. Di, and R. Malcher-Lopes
Rapid Glucocorticoid Signaling via Membrane-Associated Receptors
Endocrinology, December 1, 2006; 147(12): 5549 - 5556.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Xiao, A. Qi, and Y. Chen
Cultured Embryonic Hippocampal Neurons Deficient in Glucocorticoid (GC) Receptor: A Novel Model for Studying Nongenomic Effects of GC in the Neural System
Endocrinology, September 1, 2005; 146(9): 4036 - 4041.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. N. Hyde, A. P. Seale, E. G. Grau, and R. J. Borski
Cortisol rapidly suppresses intracellular calcium and voltage-gated calcium channel activity in prolactin cells of the tilapia (Oreochromis mossambicus)
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E626 - E633.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING
Nongenomic Steroid Action: Controversies, Questions, and Answers
Physiol Rev, July 1, 2003; 83(3): 965 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Zhu, C. D. Rice, Y. Pang, M. Pace, and P. Thomas
From the Cover: Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes
PNAS, March 4, 2003; 100(5): 2231 - 2236.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
Y.-Z. Chen and J. Qiu
Possible Genomic Consequence of Nongenomic Action of Glucocorticoids in Neural Cells
Physiology, December 1, 2001; 16(6): 292 - 296.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. E. Graham, T. A. Key, K. Kilpatrick, and R. I. Dorin
Dexras1/AGS-1, a Steroid Hormone-Induced Guanosine Triphosphate-Binding Protein, Inhibits 3',5'-Cyclic Adenosine Monophosphate-Stimulated Secretion in AtT-20 Corticotroph Cells
Endocrinology, June 1, 2001; 142(6): 2631 - 2640.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S.-H. Park, M. Taub, and H.-J. Han
Regulation of Phosphate Uptake in Primary Cultured Rabbit Renal Proximal Tubule Cells by Glucocorticoids: Evidence for Nongenomic as Well as Genomic Mechanisms
Endocrinology, February 1, 2001; 142(2): 710 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P. Thomas, J. Pinter, and S. Das
Upregulation of the Maturation-Inducing Steroid Membrane Receptor in Spotted Seatrout Ovaries by Gonadotropin During Oocyte Maturation and Its Physiological Significance
Biol Reprod, January 1, 2001; 64(1): 21 - 29.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling
Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects
Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
J. B.Mailhes, D. Young, G. Caldito, and S.N. London
Sensitivity of mouse oocytes to nicotine-induced perturbations during oocyte meiotic maturation and aneuploidy in vivo and in vitro
Mol. Hum. Reprod., March 1, 2000; 6(3): 232 - 237.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiu, J.
Right arrow Articles by Chen, Y.-z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiu, J.
Right arrow Articles by Chen, Y.-z.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals